Global Transcriptomics Market Growth (Status and Outlook) 2025-2031

Global Transcriptomics Market Growth (Status and Outlook) 2025-2031

The global Transcriptomics market size is predicted to grow from US$ 4462 million in 2025 to US$ 8068 million in 2031; it is expected to grow at a CAGR of 10.4% from 2025 to 2031.

Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.

North America is the largest consumption place, with a consumption market share nearly 55% . Following North America, Europe is the second largest consumption place with the consumption market share of 25% .The key manufacturers are Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories, Fluidigm etc. Top 3 companies occupied about 41% market share.

LPI (LP Information)' newest research report, the “Transcriptomics Industry Forecast” looks at past sales and reviews total world Transcriptomics sales in 2024, providing a comprehensive analysis by region and market sector of projected Transcriptomics sales for 2025 through 2031. With Transcriptomics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transcriptomics industry.

This Insight Report provides a comprehensive analysis of the global Transcriptomics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Transcriptomics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Transcriptomics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transcriptomics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transcriptomics.

This report presents a comprehensive overview, market shares, and growth opportunities of Transcriptomics market by product type, application, key players and key regions and countries.

Segmentation by Type:
PCR
Microarray
Sequencing

Segmentation by Application:
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm